Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal protrusion
abducens nerve paralysis
acetylcholine receptor antibody
activities of daily living
acyl CoA dehydrogenase deficiency
advances in neurology
adverse drug reaction
amantadine
amaurosis fugax
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, inflammatory type
amyloid beta-related angiitis
anesthesia, general
aneurysm
aneurysm, cavernous sinus
aneurysm, cavernous sinus-bilateral
aneurysm, intracranial
anticholinergic drugs
anticholinergic drugs, side effects of
antihistamines
antithyroid antibodies
anxiety
apomorphine
atheromatous branch disease, intracranial
atrial fibrillation
atypical
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
basilar artery occlusion
benserazide
biotin
biotin deficiency
biotin deficiency, juvenile form
biotin-responsive basal ganglia disease
bladder dysfunction
blindness
blindness, transient
blinking, reduced
bradykinesia
brain biopsy
brainstem, infarction of
brainstem, syndrome
bridge therapy
bromocriptine
burning paresthesia
cabergoline
camptocormia
capsular warning syndrome
carbidopa
cardiomyopathy
carnitine deficiency
carnitine deficiency myopathy
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, false negative
CAT scan, negative
catechol-o-methyltransferase inhibitor
cavernous hemangioma
cavernous sinus, syndrome
cerebral cortex
cerebral embolism
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, delay in treatment
cerebrovascular accident, delayed onset
cerebrovascular accident, multiple
cerebrovascular accident, stuttering
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time to treatment
cerebrovascular accident, young adult
Charcot-Marie-Tooth
children
chromosome 6
Clinical Pathologic Conference(C.P.C.)
clinical trials
clot retrieval
clozapine
cognition
complications
confusion
controversies in neurology
corpus callosum
corpus callosum, lesion of
cortical blindness, transient
cost effectiveness
cough
cranial neuropathy
cranial neuropathy, multiple
cycling
cyclophosphamide
deep gray nuclei
delay in diagnosis
dementia
deprenyl
depression
diagnostic criteria
diet
differential diagnosis
diplopia
diplopia, transient
diplopia, vertical
disability rating scale, neurological
disability, neurological
disorientation
dizziness
dopamine agonist
dopamine receptor, D2
dysarthria
dyskinesia
dyskinesia, drug induced
dysphagia
dysphonia
dyspnea
dystonia
dystonia, painful
efficacy
electroencephalogram, abnormalities of
electromyogram
electromyogram, decremental response
embolism
encephalitis
encephalitis, viral
encephalopathy
encephalopathy, Hashimoto's
endovascular therapy
enophthalmous
entacapone
enzyme inhibition
episodic disorders
episodic neurologic deficits
evidence-based research
exercise
exercise-induced neurologic dysfunction
eye movement, disorders of
eye, pain in
facial weakness
falling
familial
fatigue
fever
fibrinolytic agents
fibrinolytic agents, contraindications
fibrinolytic therapy, selection criteria
fluctuate
fluorescein angiography
frontal lobe, behavior with disease of
fundus, abnormality of
gait disorder
gait, festinating
gastrostomy
gaze palsy
gaze palsy, horizontal
gaze palsy, horizontal-bilateral
gene
gene mutation
gene therapy
genetic neurologic disorders
genu of corpus callosum
glabellar sign
globus pallidus
globus pallidus focused ultrasound ablation
globus pallidus, lesion of
globus pallidus, stimulation
hallucination
handwriting
headache
headache, frontal
headache, recurrent
headache, sudden onset of
headache, unilateral
hearing loss
hearing loss, fluctuating
hematoma, intracerebral
hemianopia, homonymous
hemiparesis
hemiparesis, fluctuating
hemiparesis, transient
hemosiderosis, subarachnoid
hepatomegaly
hunger
hypoglycemia
hypometric saccades
iatrogenic neurologic disorders
imbalance
imbalance, postural
immunosuppressive agents
insomnia
intellectual deficit
intracerebral hemorrhage
intranasal medication
intubation
kinesia paradoxica
laser shoes
L-dopa
L-dopa, controlled release
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
L-dopa, enteral infusion, continuous
L-dopa, liquid
L-dopa, plasma concentration
L-dopa, potentiators of
level of consciousness
level of consciousness, decreased
level of consciousness, fluctuating
Lewy body
limbic encephalitis
lipid storage myopathy
lithium
livedo reticularis
madopar
malformation, vascular
malformation, vascular, cerebral
marche a petits pas
masked facies
maxillary sinus mucocele
memory, defect of recent
memory, impairment of
Meniere's disease
meningeal enhancement
mental status, abnormal
metabolic acidosis
microaneurysm, retinal
microangiopathy, brain
micrographia
microhemorrhage, intracerebral
microinfarcts
middle cerebral artery, occlusion of
migraine
mimics
misdiagnosis
monoamine oxidase inhibitors
monoparesis
mortality
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, angiography
MRI, contrast enhanced
MRI, cortical enhancement
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, gray matter enhancement
MRS
muscle biopsy
muscle pain
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, cold test for
myasthenia gravis, diagnosis
myasthenia gravis, misdiagnosis of
myasthenia gravis, neuromuscular junction in
myasthenia gravis, receptor site in
myopathy
myopathy, proximal
nasal speech
nausea and vomiting
neck weakness
nerve conduction studies
neuroleptic, atypical
neurologic complications of, surgery
neurologic disease, diagnoses of
neurologic disease, tempo
neurologic examination
neurologic examination, fluctuating
neurologic history
neurologic signs
neurologic symptoms
neurology clinic, urgent
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuromuscular junction, abnormality of
neuroophthalmology
neuropathology
neuropathy
night sweats
NIH scale, fluctuating
NIH stroke scale
NIH stroke scale, fluctuating
old age, neurology of
ophthalmoplegia
ophthalmoplegia, bilateral, acute
ophthalmoplegia, recurrent
ophthalmoplegia, total
optic neuropathy
orbit
orbit, lesions of
orthostatic hypotension
pain
pain, periorbital
pallidotomy
panic attacks
paralysis
paralysis, recurrent
paresthesias
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, diet restricted in protein
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, freezing phenomena in
Parkinson disease, intractable
Parkinson disease, L-dopa nonresponsive
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism syndrome
patient information and support
peek sign
pergolide
personality change
phenothiazine
PHNO
PHNO, enteral infusion, continuous
PHNO, intravenous
photopsias
pleocytosis of cerebrospinal fluid
pons, infarction of
pontine warning syndrome
positive visual phenomena
practice guidelines
pramipexole
pramipexole, extended release
precipitating factors
PRKN gene
procyclidine
prognosis
progressive neurologic disorder
ProSavin
protocol violations
pseudomyasthenia
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
ptosis
ptosis, unilateral
pyridoxine
quadriparesis
quadriplegia, transient
quality of life
quetiapine
rasagiline
recurrent
repetitive nerve stimulation
reserpine and reserpine like drugs
retina, abnormal
retinal artery occlusion
retinal branch artery occlusion
retinal microvascular disease
retinopathy
retro-orbital pain
reversible neurologic disorder
review article
rigidity
risk factors
risk-benefit assessment
ropinirole
ropinirole, prolonged release
safety
Saudi Arabia
seizure
sinemet
sinuses, diseases of
sinusitis
sleep
spasticity
speech disorder
speech disorder, non aphasic
speech, loss of
speech, soft
spinal cord, blood supply of
splenium of corpus callosum
Stalevo
stare
stereotaxic surgery
steroid responsive encephalopathy
stimulation, deep brain
striatum, lesion of
striatum, lesion of, bilateral
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subthalamic nucleus
subthalamic nucleus deep brain stimulation
Susac's syndrome
symmetric brain lesions
temporal lobe, lesion, bilateral
tensilon test
thalamus, lesion of
third nerve palsy
third nerve palsy, partial
third nerve palsy, pupil sparing in
tissue plasminogen activator, intravenous
tolcapone
tonic foot response
transient ischemic attack
transient neurologic deficit
treatment of neurologic disorder
tremor
tremor, resting
tremor, surgical treatment of
tremor, thalamic stimulation for suppression of
trigeminal neuralgia
trigeminal neuropathy
twins
Unified Parkinson Rating Scale
vasculopathy
vertigo
vertigo, episodic
vertigo, migraine causing
visual acuity, decreased
visual loss
visual loss, transient
visual symptoms
visual symptoms, cardio-vascular disease causing
vitamin, multiple
walking, difficulty with
weakness
weakness, end of day
weakness, fatiguable
weakness, fluctuating
weakness, generalized
weakness, proximal
wheelchair
white matter disease
Showing articles 50 to 87 of 87 << Previous

Entacapone Improves Motor Fluctuations in Levodopa-Treated Parkinson's Dis Pts
Parkinson Study Group, Ann Neurol 42:747-7551997., , 1997

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996

Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

The Spectrum of Levodopa-Related Fluctuations in Parkinson's Disease
Neurol 43:1459-1464, Riley,D.E.&Lang,A.E., 1993

Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993

Intranasal Apomorphine in Parkinsonian On-Off Fluctuations
Arch Neurol 49:482-484, vanLaar,T.,et al, 1992

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Protein Redistribution Diet Remains Effective in Patients with Fluctuating Parkinsonism
Arch Neurol 49:149-151, Karstaedt,P.J.&Pincus,J.H., 1992

Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991

Intranasal Apomorphine in Parkinson's Disease
Neurol 41:761-762, Kleedorfer,B.,et al, 1991

Standard & Controlled-Release Levodopa/Carbidopa in Fluctuating Parkinson's Disease on a Protein Redistribution Diet
Arch Neurol 48:402-405, Karstaedt,P.J.,et al, 1991

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990

Unilateral Cavernous Angioma of the Thalamus Disclosed by Transitional Disorders in the Upward Gaze
Minerva Medica 81:731-733, Lazzarino,L.G.,et al, 1990

Amount and Distribution of Dietary Protein Affects Clinical Response to Levodopa in Parkinson's Disease
Neurol 39:552-556, Carter,J.H., 1989

The Effect of Dietary Protein on the Efficacy of L-Dopa:A Double-Blind Study
Neurol 39:549-552, Tsui,J.K.,et al, 1989

Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988

Protein Redistribution Diet Restores Motor Function in Patients with Dopa-Resistant"Off"Periods
Neurol 38:481-483, Pincus,J.H.&Barry,K., 1988

Long-Term Duodenal Infusion of Levodopa for Motor Fluctuations in Parkinsonism
Ann Neurol 24:87-89, Sage,J.I.,et al, 1988

Dietary Therapy for Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:1119-1121, Kurlan,R., 1987

Pathophysiology & Clinical Assessment of Motor Symptoms in Parkinson's Disease
In Handbk of Parkinson's Disease, Marcel Dekker, Inc, New York, p997., Jankovic,J., 1987

Painful Parkinson's Disease
Lancet 1:1366-1369, Quinn,N.P.,et al, 1986

The"On-Off"Phenomenon in Parkinson's Disease
NEJM 310:483-488, Nutt,J.G.,et al, 1984

Treatment of the"On-Off"Phenomenon Parkinsonism with Lithium Carbonate
Ann Neurol 12:375-379, Coffey,C.E.,et al, 1982

Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982

Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982

Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979

Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979

Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979

The L-Dopa On-Off Effect in Parkinson Disease:Treat. by Trans. Drug Withdrawal & Dopamine Receptor Resens
Ann Neurol 4:573-575, Direnfeld,L.,et al, 1978

Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976



Showing articles 50 to 87 of 87 << Previous